1-2 of 2
Keywords: Treatment duration
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Duration of Targeted Therapy for Metastatic Renal Cell Carcinoma: A Review of Current Practices

Subject Area:
Oncology
Sylvie Négrier
Journal: Oncology
Oncology (2012) 82 (4): 189–196.
https://doi.org/10.1159/000336888
Published Online: 21 March 2012
... with targeted agents that are approved for first-line treatment of metastatic renal cell carcinoma and considers the reasons for switching or discontinuing therapy. In addition, practical strategies for achieving optimal treatment duration, through adverse event management, are discussed. Median duration...
View article titled, Duration of Targeted Therapy for Metastatic Renal Cell Carcinoma: A Review of Current Practices
Open the PDF for Duration of Targeted Therapy for Metastatic Renal Cell Carcinoma: A Review of Current Practices in another window
Journal Articles

Imatinib in Gastrointestinal Stromal Tumor: Does Treatment Duration Matter?

Subject Area:
Oncology
Antoine Adenis, Nicolas Penel, Jean-Yves Blay
Journal: Oncology
Oncology (2009) 77 (3-4): 157–161.
https://doi.org/10.1159/000236019
Published Online: 04 September 2009
... survival for some patients with a localized and resectable tumor. This reviewprovides a clinical perspective on the available data, evidence- or expert-based, for calculating the optimal treatment duration with imatinib. 16 01 2009 19 04 2009 4 9 2009 © 2009 S. Karger AG, Basel 2009...
View article titled, Imatinib in Gastrointestinal Stromal Tumor: Does <span class="search-highlight">Treatment</span> <span class="search-highlight">Duration</span> Matter?
Open the PDF for Imatinib in Gastrointestinal Stromal Tumor: Does <span class="search-highlight">Treatment</span> <span class="search-highlight">Duration</span> Matter? in another window